These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 27600953)
1. Considering new treatment paradigms for neuropsychiatric symptoms of Alzheimer's disease. Lanctôt KL; Boot BP; Bain LJ; Hendrix JA; Carrillo MC Alzheimers Dement; 2016 Sep; 12(9):1031-1032. PubMed ID: 27600953 [No Abstract] [Full Text] [Related]
2. Neuropsychiatric symptoms of dementia: are pharmacological treatments effective and safe? Ford AH J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):4. PubMed ID: 24876187 [No Abstract] [Full Text] [Related]
3. Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment. Chung JA; Cummings JL Neurol Clin; 2000 Nov; 18(4):829-46. PubMed ID: 11072263 [TBL] [Abstract][Full Text] [Related]
4. Psychopharmacology and Alzheimer's disease. Serby M J Adv Med Surg Nurs; 1989 Mar; 1(2):32-9. PubMed ID: 2664071 [No Abstract] [Full Text] [Related]
5. Cholinesterase inhibitors: A new class of psychotropic compounds. Cummings JL Am J Psychiatry; 2000 Jan; 157(1):4-15. PubMed ID: 10618007 [TBL] [Abstract][Full Text] [Related]
6. [Drug therapy of Alzheimer's disease]. Sulkava R Duodecim; 2000; 116(24):2867-73. PubMed ID: 12077892 [No Abstract] [Full Text] [Related]
7. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease. Cummings JL; Masterman DL J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer's disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial. Suzuki H; Gen K Psychogeriatrics; 2015 Mar; 15(1):32-7. PubMed ID: 25516380 [TBL] [Abstract][Full Text] [Related]
13. No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients. Weiner MF; Tractenberg RE; Sano M; Logsdon R; Teri L; Galasko D; Gamst A; Thomas R; Thal LJ J Geriatr Psychiatry Neurol; 2002; 15(2):95-8. PubMed ID: 12083600 [TBL] [Abstract][Full Text] [Related]